Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 5792 of 5804
-
New drug tested in healthy volunteers – no cure expected
Knowledge-focused CompletedTo investigate the safety, tolerability and pharmacokinetics of BI 425809 tablets in healthy Chinese and Japanese male subjects following the administration of single rising oral doses and further to explore the pharmacokinetics (PK) including dose proportionality of BI 425809 af…
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
New drug combo safety checked in healthy volunteers
Knowledge-focused TerminatedThe aim of the study is to investigate the safety of the concomitant administration of ACT-334441 with cardiovascular drugs.
Phase: PHASE1 • Sponsor: Viatris Innovation GmbH • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Cord blood stroke trial pulled before it even started
Disease control TerminatedAutologous human umbilical cord blood (hUCB) stored at Cord Blood Registry will be given to children who have suffered from a Perinatal Arterial Ischemic Stroke. The aim is to determine if hUCB infusion is safe, if late functional outcome is improved, if hUCB treatment improves p…
Phase: PHASE1, PHASE2 • Sponsor: James Baumgartner, MD • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug MT-8554 tested for safety in healthy people
Knowledge-focused CompletedThe purpose of this study is to investigate the safety, tolerability and pharmacokinetics of MT-8554 in healthy Caucasian subjects.
Phase: PHASE1 • Sponsor: Tanabe Pharma Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Heart gene therapy trial pulled before it even started
Disease control TerminatedThe purpose of this study is to evaluate the safety and tolerability of catheter based injections of VM202 into the heart.
Phase: PHASE1, PHASE2 • Sponsor: Helixmith Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Healthy volunteers help uncover drug interactions in early trial
Knowledge-focused CompletedThe purpose of this study is to determine the effects of a potent CYP3A4 inhibitor, itraconazole, on the steady-state PK of AVP-923 and AVP-786.
Phase: PHASE1 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New device may speed up eye exams by skipping dilation drops
Knowledge-focused CompletedThe electroretinogram (ERG) is a diagnostic test that measures the electrical activity generated by cells in the retina in response to a light stimulus. Typically, an ERG is recorded with white flash when the pupil is dilated. RETeval Visual Diagnostic Device (RETeval) generates …
Phase: NA • Sponsor: LKC Technologies, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Brain drug levels measured in healthy volunteers
Knowledge-focused CompletedTo assess the exposure of BI 425809 in cerebrospinal fluid relative to plasma as well as safety and tolerability, and to evaluate the effect of different doses of BI 425809 on biomarkers levels in cerebrospinal fluid.
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Healthy volunteer study sheds light on potential liver disease drug metabolism
Knowledge-focused CompletedIntravenous infusion of stable tracers of ornithine, glutamine, glutamate, and glycine will be performed, and collect blood samples, urine samples, and muscle biopsies to evaluate the effect of a continuous oral intake of phenylacetate salt of ornithine (OP) on its metabolic fate…
Phase: NA • Sponsor: Texas A&M University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Hepatitis b drug trial pulled before it started
Disease control TerminatedPatients with chronic HBV infection will receive ARC-520 in combination with entecavir or tenofovir and be evaluated for safety and efficacy.
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Which tube feeding method works best for head and neck cancer patients?
Symptom relief TerminatedThe purpose of this study is to assess the optimal tube feeding method (bolus, gravity or pump) by analyzing percent weight loss, tolerance of enteral feeds, and percent of estimated calorie and protein needs in 60 patients with squamous cell carcinoma of the head and neck underg…
Phase: NA • Sponsor: Baylor Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New drug BI 425809 tested in healthy people for safety
Knowledge-focused CompletedThe aim of the study is to investigate the safety, tolerability, and pharmacokinetics of multiple rising doses of BI 425809 tablets given orally once daily for 12 days to young and elderly healthy male and female volunteers and to compare single dose pharmacokinetics of BI 425809…
Phase: PHASE1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Head tilt changes foot pressure, study finds
Knowledge-focused CompletedWhen examining a subject in quiet stance from the side, the leg segment is usually seen to be oriented upwards and forwards by about 5°; the knee may be flexed by a few degrees, the shoulders are behind the great trochanter and the head is held forwards. The forward head position…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Researchers compare three methods to measure pelvic extension in healthy volunteers
Knowledge-focused CompletedThe main objective of this study is to describe for the first time the expansion reserve of the pelvic area (measurements using the EOS system) for each of the four morphotypes (Roussouly classification) commonly found in a population of healthy volunteers.
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Insulin formula Shake-Up: new versions tested in healthy volunteers
Knowledge-focused CompletedThe purposes of this study are to determine: * Part A * How quickly your body absorbs, breaks down and gets rid of the different formulations of insulin lispro compared to insulin lispro alone formulation. * The safety of insulin lispro in different formulations and any sid…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:47 UTC
-
Sepsis diagnosis study withdrawn before it began
Diagnosis TerminatedSevere sepsis and sepsis shock are common in emergency department, with a high mortality rate. The potential severity of this disease impose a diagnosis as early as possible to start antibiotic therapy and hemodynamic support. Conventional biomarkers are an important support for …
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New powered device may make bone marrow aspirations quicker and less painful
Knowledge-focused CompletedThis single center study will compare the manual standard bone marrow aspiration device to the powered ported bone marrow aspiration device for use in the iliac crest in healthy adult volunteers. The study will evaluate the subjects' perceived level of pain, time to sample acquis…
Phase: NA • Sponsor: Vidacare Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Laughing gas danger? study probes Kids' abuse risk at dentist
Knowledge-focused CompletedThe aim of this study is to evaluate the potential risk of abusive behavior for children in care using nitrous oxide for dental care.
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Healthy volunteers help sharpen cancer blood test
Knowledge-focused CompletedHuman blood will be collected to serve as control in validating clinical studies studying the detection and levels of circulating tumor cells and microvesicles in cancer patients. Targeted population is cancer-free 18-60 year old men and women. Volunteer selection will rely upon …
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Researchers Double-Check drug measurement methods
Knowledge-focused Recruiting nowThis study aims to ensure that assays that measure drug concentrations are accurate and precise in different matrices when quantified using high performance liquid chromatography -tandem mass spectrometry (HPLC-MS/MS). The study involves collecting samples of various bodily fluid…
Sponsor: University of Liverpool • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC